Literature DB >> 29703607

Progression beyond nivolumab: Stop or repeat? Dramatic responses with salvage chemotherapy.

Amaury Daste1, Erwan De-Mones2, Valérie Cochin3, Charles Dupin4, Laurence Digue5, Alain Ravaud6, Charlotte Domblides7.   

Abstract

Keywords:  Check point inhibitors; Head and neck cancer; Pseudo-progression

Year:  2018        PMID： 29703607     DOI： 10.1016/j.oraloncology.2018.04.013

Source DB:  PubMed          Journal:  Oral Oncol        ISSN： 1368-8375            Impact factor:   5.337


× No keyword cloud information.
  1 in total

1.  Safety and Efficacy of Cetuximab-Based Salvage Chemotherapy After Checkpoint Inhibitors in Head and Neck Cancer.

Authors:  María Nieves Cabrera-Martín; Salomé Merino-Menéndez; Santiago Cabezas-Camarero; Mateo Paz-Cabezas; Vanesa García-Barberán; Melchor Sáiz-Pardo Sanz; Maricruz Iglesias-Moreno; Almudena Alonso-Ovies; Pedro Pérez-Segura
Journal:  Oncologist       Date:  2021-04-08
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.